N‐methyl‐D‐aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica

Dale RC., Irani SR., Brilot F., Pillai S., Webster R., Gill D., Lang B., Vincent A.

AbstractEncephalitis lethargica (EL) describes an encephalitis with psychiatric, sleep, and extrapyramidal movement disorders. Dyskinetic and Parkinsonian forms have been described. EL shares clinical features with the anti–N‐methyl‐D‐aspartate receptor (NMDAR‐Ab) encephalitis. We studied 20 sera from pediatric patients with contemporary EL. Ten sera (from 2 males and 8 females, aged 1.3–13 years) and 6/6 cerebrospinal fluid samples were positive for NMDAR‐Ab. NMDAR‐Ab–positive patients had dyskinesias, agitation, seizures, and insomnia, whereas Parkinsonism and somnolence dominated in the NMDAR‐Ab–negative children. We were unable to identify any tumors. The dyskinetic form of EL is an NMDAR‐Ab encephalitis and can affect very young children. Ann Neurol 2009;66:704–709

DOI

10.1002/ana.21807

Type

Journal article

Publisher

Wiley

Publication Date

2009-11-01T00:00:00+00:00

Volume

66

Pages

704 - 709

Total pages

5

Permalink More information Close